You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Early Release Article, posted March 13, 2006
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Can a Potent Statin Actually Regress Coronary Atherosclerosis?

Roger S. Blumenthal, MD; Navin K. Kapur, MD

JAMA. 2006;295:(doi:10.1001/jama.295.13.jed60019).

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Since the initial report by Sones and Shirey in 1962,1 coronary angiography has been the standard method used to define the severity and extent of coronary atherosclerosis. By only providing a silhouette of the coronary lumen, however, coronary angiography frequently underestimates the true burden of atheroma in the arterial wall. In this issue of JAMA, Nissen et al present important new data on coronary atherosclerosis based on their findings from the ASTEROID (A Study To Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden) trial.2 This multicenter, intravascular ultrasound (IVUS) study assessed the extent of coronary atheroma at baseline and after 2 years of treatment with the maximally approved dose (40 mg) of rosuvastatin, the statin most effective at reducing levels of low-density lipoprotein cholesterol (LDL-C). Each pair of baseline and 24-month IVUS studies was analyzed in blinded fashion.

. . . [Full Text of this Article]

Author Affiliations: The Johns Hopkins Ciccarone Preventive Cardiology Center, Baltimore, Md.


RELATED ARTICLE

Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
, , , , , , , , , , , , , , , , and
JAMA. ;295():1556-1565.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice
Glaros et al.
J. Lipid Res. 2008;49:324-331.
ABSTRACT | FULL TEXT  

Atherosclerosis Regression, Vascular Remodeling, and Plaque Stabilization
Klein
J Am Coll Cardiol 2007;49:271-273.
FULL TEXT  

High-Intensity Statin Therapy Leads to Regression of Coronary Atherosclerosis
JWatch Emergency Med. 2006;2006:3-3.
FULL TEXT  

High-Intensity Lipid Lowering Reduces Atheroma Volume
Journal Watch Cardiology 2006;2006:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.